2013 Q4 Form 10-Q Financial Statement

#000110465913082192 Filed on November 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $746.0K $629.0K $674.0K
YoY Change -46.6% -6.68% 43.71%
Cost Of Revenue $660.0K $459.0K $316.0K
YoY Change 6.45% 45.25%
Gross Profit $80.00K $170.0K $358.0K
YoY Change -89.74% -52.51% -23.83%
Gross Profit Margin 10.72% 27.03% 53.12%
Selling, General & Admin $3.440M $2.995M $3.170M
YoY Change -2.27% -5.52% -18.61%
% of Gross Profit 4300.0% 1761.76% 885.47%
Research & Development $4.600M $4.520M $4.930M
YoY Change -36.11% -8.32% -19.84%
% of Gross Profit 5750.0% 2658.82% 1377.09%
Depreciation & Amortization $190.0K $210.0K $310.0K
YoY Change -29.63% -32.26% -13.89%
% of Gross Profit 237.5% 123.53% 86.59%
Operating Expenses $8.050M $2.995M $3.170M
YoY Change -21.84% -5.52% -18.61%
Operating Profit -$7.967M -$6.498M -$7.743M
YoY Change -16.31% -16.08% -19.17%
Interest Expense $40.00K $27.00K
YoY Change 48.15% 42.11%
% of Operating Profit
Other Income/Expense, Net -$10.00K -$9.000K -$2.000K
YoY Change -90.0% 350.0%
Pretax Income -$7.970M -$6.720M -$7.750M
YoY Change -16.28% -13.29% -18.93%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$8.630M -$7.250M -$7.750M
YoY Change -9.35% -6.45% -18.93%
Net Earnings / Revenue -1156.84% -1152.62% -1149.85%
Basic Earnings Per Share -$0.24 -$0.21 -$0.23
Diluted Earnings Per Share -$0.24 -$0.21 -$0.23
COMMON SHARES
Basic Shares Outstanding 34.58M shares 34.52M shares 34.24M shares
Diluted Shares Outstanding 34.24M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.20M $25.70M $47.80M
YoY Change -56.16% -46.23% -34.25%
Cash & Equivalents $7.698M $8.872M $17.41M
Short-Term Investments $11.50M $16.90M $30.40M
Other Short-Term Assets $2.900M $900.0K $700.0K
YoY Change 314.29% 28.57% 40.0%
Inventory $1.921M $3.400M $3.028M
Prepaid Expenses
Receivables $997.0K $501.0K $654.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $25.23M $30.94M $52.88M
YoY Change -48.46% -41.48% -28.48%
LONG-TERM ASSETS
Property, Plant & Equipment $793.0K $891.0K $1.634M
YoY Change -41.61% -45.47% -28.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $5.800M
YoY Change -100.0% -60.0%
Other Assets $95.00K $50.00K $95.00K
YoY Change 0.0% -47.37% -86.43%
Total Long-Term Assets $1.507M $1.560M $8.090M
YoY Change -66.92% -80.72% -53.71%
TOTAL ASSETS
Total Short-Term Assets $25.23M $30.94M $52.88M
Total Long-Term Assets $1.507M $1.560M $8.090M
Total Assets $26.74M $32.50M $60.97M
YoY Change -50.03% -46.69% -33.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $579.0K $422.0K $240.0K
YoY Change -53.04% 75.83% -52.0%
Accrued Expenses $4.892M $3.190M $3.500M
YoY Change 39.02% -8.86% -2.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.195M $4.300M $4.852M
YoY Change 3.53% -11.38% -30.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $145.0K $0.00 $128.0K
YoY Change 10.69% -100.0% -99.65%
Total Long-Term Liabilities $145.0K $0.00 $128.0K
YoY Change 10.69% -100.0% -99.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.195M $4.300M $4.852M
Total Long-Term Liabilities $145.0K $0.00 $128.0K
Total Liabilities $6.340M $4.300M $5.077M
YoY Change 2.76% -15.3% -88.34%
SHAREHOLDERS EQUITY
Retained Earnings -$272.5M -$263.9M -$232.5M
YoY Change 12.6% 13.5%
Common Stock $293.0M $292.2M $288.4M
YoY Change 1.25% 1.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.40M $28.20M $55.89M
YoY Change
Total Liabilities & Shareholders Equity $26.74M $32.50M $60.97M
YoY Change -50.03% -46.69% -33.3%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$8.630M -$7.250M -$7.750M
YoY Change -9.35% -6.45% -18.93%
Depreciation, Depletion And Amortization $190.0K $210.0K $310.0K
YoY Change -29.63% -32.26% -13.89%
Cash From Operating Activities -$6.440M -$5.920M -$6.280M
YoY Change -12.02% -5.73% -19.69%
INVESTING ACTIVITIES
Capital Expenditures -$90.00K -$10.00K -$110.0K
YoY Change -1000.0% -90.91% -21.43%
Acquisitions
YoY Change
Other Investing Activities $5.360M $2.900M $11.66M
YoY Change 19.64% -75.13% 108.96%
Cash From Investing Activities $5.270M $2.890M $11.55M
YoY Change 17.63% -74.98% 111.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -6.440M -5.920M -6.280M
Cash From Investing Activities 5.270M 2.890M 11.55M
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -1.170M -3.030M 5.270M
YoY Change -58.8% -157.5% -321.43%
FREE CASH FLOW
Cash From Operating Activities -$6.440M -$5.920M -$6.280M
Capital Expenditures -$90.00K -$10.00K -$110.0K
Free Cash Flow -$6.350M -$5.910M -$6.170M
YoY Change -13.37% -4.21% -19.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7251000 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7745000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21879000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34435129 shares
CY2012 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
38885000 USD
CY2013Q3 us-gaap Investments And Cash
InvestmentsAndCash
25748000 USD
CY2013Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12000 USD
us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34243792 shares
mblx Inventory Obsolescence For Raw Material And Finished Goods
InventoryObsolescenceForRawMaterialAndFinishedGoods
317000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
82309 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34243792 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34435129 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34270455 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6199523 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5669132 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5679919 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5417159 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
82309 shares
CY2013Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
854000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
640000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2000 USD
CY2013Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2534000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2562000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
3400000 USD
CY2013Q3 us-gaap Deferred Revenue
DeferredRevenue
104000 USD
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
257000 USD
CY2013Q3 mblx Inventory Obsolescence For Raw Material And Finished Goods
InventoryObsolescenceForRawMaterialAndFinishedGoods
46000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
31696000 USD
CY2013Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
16871000 USD
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
13000 USD
CY2013Q3 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
5000 USD
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
31709000 USD
CY2013Q3 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
16876000 USD
mblx Long Term Investments Maximum Maturity Period
LongTermInvestmentsMaximumMaturityPeriod
P2Y
mblx Available For Sale Securities Average Maturity
AvailableForSaleSecuritiesAverageMaturity
P3M
CY2012 mblx Available For Sale Securities Average Maturity
AvailableForSaleSecuritiesAverageMaturity
P4M
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
29201000 USD
CY2013Q3 us-gaap Short Term Investments
ShortTermInvestments
16876000 USD
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
291828000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-59000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-263911000 USD
us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
4504000 USD
CY2013Q3 us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
855000 USD
CY2012Q3 us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
674000 USD
us-gaap Segment Reporting Information Revenue
SegmentReportingInformationRevenue
40919000 USD
CY2012Q4 us-gaap Long Term Investments
LongTermInvestments
2508000 USD
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1877000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2379000 USD
CY2013Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
433000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
301000 USD
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
880000 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
839000 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3190000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3519000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5579042 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6142249 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1053915 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
7550 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
142382 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
340776 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3573589 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.68
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.74
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.64
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.82
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.60
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.38
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.16
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
764000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2441000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
852000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2954000 USD
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4272000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M13D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0071 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0067 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0190 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0115 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.84 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.84 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.85 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.87 pure
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 item
us-gaap Sales Revenue Net
SalesRevenueNet
4504000 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
674000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
40919000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1358000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
891000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
316000 USD
CY2013Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2013Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2012Q4 mblx Operating Loss Carryforwards Attributable To Deduction Related To Exercise Of Stock Options
OperatingLossCarryforwardsAttributableToDeductionRelatedToExerciseOfStockOptions
19213000 USD
mblx Maximum Period To Audit For Loss
MaximumPeriodToAuditForLoss
P3Y
CY2013Q3 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
mblx Provision For Income Taxes For Undistributed Earnings Of Foreign Subsidiaries
ProvisionForIncomeTaxesForUndistributedEarningsOfForeignSubsidiaries
0 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
0 USD
CY2012Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
252000 USD
us-gaap Restructuring And Related Cost Cost Incurred To Date
RestructuringAndRelatedCostCostIncurredToDate
920000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 26pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></p> <p style="TEXT-INDENT: 26pt; MARGIN: 0in 0in 0pt;">&#160;</p> </div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Concentration of Credit Risk</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 27pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash and cash equivalents and short-term investments. The Company primarily invests its excess cash and cash equivalents in money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments are acquired in accordance with the Company&#8217;s investment policy which establishes a concentration limit per issuer.</font></p> <p style="TEXT-INDENT: 27pt; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 27pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company provides credit to customers in the normal course of business. The Company performs ongoing credit evaluations of its customers&#8217; financial condition and limits the amount of credit extended when deemed necessary. At September&#160;30, 2013, the Company&#8217;s accounts and unbilled receivables include $571 or 66% from U.S. and Canadian government grants and $140 or 16% from customer product sales. At December&#160;31, 2012, the Company&#8217;s accounts and unbilled receivables included $561 or 46% from U.S. and Canadian government grants and $535 or 44% from customer product sales. At September&#160;30, 2013, no customer had accounts receivable due from product sales representing 10% or more of our total accounts receivable.&#160; At December&#160;31, 2012, one customer had accounts receivable due from product sales representing 41% of our total accounts receivable.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> </div>
CY2013Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
271000 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
932000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
30943000 USD
CY2013Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
619000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50000 USD
dei Entity Registrant Name
EntityRegistrantName
METABOLIX, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001121702
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34581449 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8872000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
501000 USD
CY2013Q3 us-gaap Assets
Assets
32503000 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
422000 USD
CY2013Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
97000 USD
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
450000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4300000 USD
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
265000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
4300000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
345000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
28203000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32503000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14572000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
839000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1876000 USD
CY2012Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
75000 USD
CY2012Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
372000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
692000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
48955000 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1067000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5984000 USD
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
55000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
131000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
6170000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
343000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
594000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2012Q4 us-gaap Assets
Assets
53510000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1233000 USD
CY2012Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
165000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
289050000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-242032000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
47340000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53510000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34306570 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34516762 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34306570 shares
CY2013Q3 us-gaap Revenue From Grants
RevenueFromGrants
563000 USD
CY2012Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
27000 USD
CY2013Q3 mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
27000 USD
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
459000 USD
CY2013Q3 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
4643000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2995000 USD
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
8097000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7242000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
102000 USD
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000 USD
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9000 USD
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2012Q3 us-gaap Revenue From Grants
RevenueFromGrants
576000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
70000 USD
mblx Revenue From Termination Of Collaboration With Subsidiary
RevenueFromTerminationOfCollaborationWithSubsidiary
38885000 USD
CY2012Q3 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
4931000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3170000 USD
CY2012Q3 us-gaap Costs And Expenses
CostsAndExpenses
8417000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7743000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-29000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000 USD
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
mblx Research And Development Revenue
ResearchAndDevelopmentRevenue
618000 USD
mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
139000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2212000 USD
mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
14446000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9728000 USD
us-gaap Costs And Expenses
CostsAndExpenses
26386000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-21882000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
43000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-40000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000 USD
us-gaap Revenue From Grants
RevenueFromGrants
1415000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
457000 USD
mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
162000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
808000 USD
mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
15982000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11006000 USD
us-gaap Costs And Expenses
CostsAndExpenses
27796000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
13123000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-78000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
24000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3028000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-811000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-272000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-360000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-8000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-338000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-29000 USD
CY2012Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3000 USD
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
15000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13139000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21916000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7250000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
737000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1026000 USD
mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
356000 USD
mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
350000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2441000 USD
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
141000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-311000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-94000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
513000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-101000 USD
mblx Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
-254000 USD
mblx Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
-115000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-617000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-37900000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-20214000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-24424000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
281000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
397000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
12000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
25000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-28000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
141000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
56428000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
30447000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
77320000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
14520000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
20535000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
15621000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
508000 USD
us-gaap Inventory Write Down
InventoryWriteDown
317000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
14000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-20000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-3872000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17405000 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-101000 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
363000 USD
CY2013Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
91000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD

Files In Submission

Name View Source Status
0001104659-13-082192-index-headers.html Edgar Link pending
0001104659-13-082192-index.html Edgar Link pending
0001104659-13-082192.txt Edgar Link pending
0001104659-13-082192-xbrl.zip Edgar Link pending
a13-19709_110q.htm Edgar Link pending
a13-19709_1ex31d1.htm Edgar Link pending
a13-19709_1ex31d2.htm Edgar Link pending
a13-19709_1ex32d1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mblx-20130930.xml Edgar Link completed
mblx-20130930.xsd Edgar Link pending
mblx-20130930_cal.xml Edgar Link unprocessable
mblx-20130930_def.xml Edgar Link unprocessable
mblx-20130930_lab.xml Edgar Link unprocessable
mblx-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending